Barrington Research Maintains Outperform on Concentrix, Raises Price Target to $121
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Vincent Colicchio has maintained an Outperform rating on Concentrix (NASDAQ:CNXC) and increased the price target from $98 to $121.
January 25, 2024 | 3:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Concentrix's stock may see a positive impact in the short term due to Barrington Research's raised price target from $98 to $121 and maintained Outperform rating.
Analyst ratings and price target adjustments are significant indicators for investors. The increase in price target by Barrington Research suggests a bullish outlook on Concentrix, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100